Streptococcus pyogenes Employs Strain-dependent Mechanisms of C3b Inactivation to Inhibit Phagocytosis and Killing of Bacteria*

Evasion of complement-mediated opsonophagocytosis enables group A Streptococcus pyogenes (GAS) to establish infection. Different strain-dependent mechanisms are employed by the host to accomplish this goal. In general, GAS inhibits the amplification of the complement cascade on its cell surface by facilitating the degradation of C3b, an opsonin, to an inactive product, inactivated C3b (iC3b), in a step catalyzed by factor I (FI) and its cofactor, factor H (FH), with or without the participation of human host plasmin (hPm). GAS recruits FH to its cell surface via FH receptors, which are transcriptionally controlled by the two-component cluster of virulence responder-sensor system. The manner in which FI-FH and hPm function together on GAS cells is unknown. Using GAS strain AP53, which strongly binds host human plasminogen/plasmin (hPg/hPm) directly via an hPg/hPm surface receptor (PAM), we show that both FI-FH and hPm sequentially cleave C3b. Whereas FI-FH proteolytically cleaves C3b into iC3b, PAM-bound hPm catalyzes cleavage of iC3b into multiple smaller peptides. Unlike AP53, GAS strain M23ND weakly binds FH and recruits hPg/hPm to its cell surface indirectly via fibrinogen bound to M-protein, M23. In this case, FH-FI cleaves C3b into iC3b, with negligible degradation of iC3b by hPm that is bound to fibrinogen on the cells. AP53 and M23ND display similar resistance to human neutrophil-mediated phagocytosis, which results in a corresponding high lethality in mice after injection of these cells. These results suggest that GAS utilizes diverse mechanisms to degrade C3b and thus to protect bacterial cells from the complement response of the host.

[1]  F. Castellino,et al.  Direct Host Plasminogen Binding to Bacterial Surface M-protein in Pattern D Strains of Streptococcus pyogenes Is Required for Activation by Its Natural Coinherited SK2b Protein* , 2015, The Journal of Biological Chemistry.

[2]  E. Conway,et al.  Interplay between fibrinolysis and complement: plasmin cleavage of iC3b modulates immune responses , 2015, Journal of thrombosis and haemostasis : JTH.

[3]  F. Castellino,et al.  Unique Genomic Arrangements in an Invasive Serotype M23 Strain of Streptococcus pyogenes Identify Genes That Induce Hypervirulence , 2014, Journal of bacteriology.

[4]  R. Balsara,et al.  Complement-mediated Opsonization of Invasive Group A Streptococcus pyogenes Strain AP53 Is Regulated by the Bacterial Two-component Cluster of Virulence Responder/Sensor (CovRS) System* , 2013, The Journal of Biological Chemistry.

[5]  J. Carapetis,et al.  Group A streptococcal vaccines: paving a path for accelerated development. , 2013, Vaccine.

[6]  G. Lindahl,et al.  Factor H Binds to the Hypervariable Region of Many Streptococcus pyogenes M Proteins but Does Not Promote Phagocytosis Resistance or Acute Virulence , 2013, PLoS pathogens.

[7]  Yueling Zhang,et al.  A Natural Inactivating Mutation in the CovS Component of the CovRS Regulatory Operon in a Pattern D Streptococcal pyogenes Strain Influences Virulence-associated Genes* , 2013, The Journal of Biological Chemistry.

[8]  P. Zipfel,et al.  Plasminogen Is a Complement Inhibitor* , 2012, The Journal of Biological Chemistry.

[9]  V. Nizet,et al.  Molecular insight into invasive group A streptococcal disease , 2011, Nature Reviews Microbiology.

[10]  John D Lambris,et al.  Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.

[11]  T. Foster,et al.  Clumping Factor A Interaction with Complement Factor I Increases C3b Cleavage on the Bacterial Surface of Staphylococcus aureus and Decreases Complement-Mediated Phagocytosis , 2010, Infection and Immunity.

[12]  M. Ward,et al.  Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. , 2008, The Journal of infectious diseases.

[13]  S. Hamada,et al.  Group A Streptococcal Cysteine Protease Degrades C3 (C3b) and Contributes to Evasion of Innate Immunity* , 2008, Journal of Biological Chemistry.

[14]  K. Hong Characterization of Group A Streptococcal M23 Protein and Comparison of the M3 and M23 Protein’s Ligand-Binding Domains , 2007, Current Microbiology.

[15]  V. Nizet,et al.  How group A Streptococcus circumvents host phagocyte defenses. , 2007, Future microbiology.

[16]  J. Carapetis,et al.  The global burden of group A streptococcal diseases. , 2005, The Lancet. Infectious diseases.

[17]  A. Bisno,et al.  Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  G. Lindahl,et al.  Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway , 2005, Molecular microbiology.

[19]  Robert B Sim,et al.  The catalytically active serine protease domain of human complement factor I. , 2005, Biochemistry.

[20]  D. Pérez-Caballero,et al.  Interaction between Complement Regulators and Streptococcus pyogenes: Binding of C4b-Binding Protein and Factor H/Factor H-Like Protein 1 to M18 Strains Involves Two Different Cell Surface Molecules1 , 2004, The Journal of Immunology.

[21]  L. Rozek,et al.  Plasminogen Is a Critical Host Pathogenicity Factor for Group A Streptococcal Infection , 2004, Science.

[22]  J. R. Smith,et al.  Phagocytosis of opsonized apoptotic cells: roles for ‘old‐fashioned’ receptors for antibody and complement , 2004, Clinical and experimental immunology.

[23]  D. Cue,et al.  Acquisition of Regulators of Complement Activation by Streptococcus pyogenes Serotype M1 , 2002, Infection and Immunity.

[24]  R. Ezekowitz Local opsonization for apoptosis? , 2002, Nature Immunology.

[25]  S. Hamada,et al.  Fba, a novel fibronectin‐binding protein from Streptococcus pyogenes, promotes bacterial entry into epithelial cells, and the fba gene is positively transcribed under the Mga regulator , 2001, Molecular microbiology.

[26]  D. Marti,et al.  Kringle 2 Mediates High Affinity Binding of Plasminogen to an Internal Sequence in Streptococcal Surface Protein PAM* , 1998, The Journal of Biological Chemistry.

[27]  A. Podbielski,et al.  Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci. , 1997, The Journal of infectious diseases.

[28]  M. Wessels,et al.  Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus , 1997, Infection and immunity.

[29]  R. Lottenberg,et al.  The plasmin-binding protein Plr of group A streptococci is identified as glyceraldehyde-3-phosphate dehydrogenase. , 1996, Microbiology.

[30]  D. Bessen,et al.  Genetic correlates of throat and skin isolates of group A streptococci. , 1996, The Journal of infectious diseases.

[31]  W. Müller-Esterl,et al.  Identification of a plasminogen‐binding motif in PAM, a bacterial surface protein , 1995, Molecular microbiology.

[32]  U. Sjöbring,et al.  PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. , 1993, The Journal of biological chemistry.

[33]  V. Fischetti,et al.  Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Schreiber,et al.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution , 1977, The Journal of experimental medicine.

[35]  M. Dierich,et al.  Third component of complement (C3): structural properties in relation to functions. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Ralph,et al.  Group a streptococcal diseases and their global burden. , 2013, Current topics in microbiology and immunology.

[37]  Wen-chao Song,et al.  Complement and its role in innate and adaptive immune responses , 2010, Cell Research.